Related Experiment Video
Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Alzheimer's Imaging Consortium.
Vladimir S Fonov1, Pedro Rosa-Neto1,2, D Louis Collins1,3
1McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
This study predicts Alzheimer's disease (AD) progression risk by analyzing brain structure volumes against healthy aging models. The method effectively identifies individuals at high risk for AD conversion using neuroimaging data.
Area of Science:
- Neuroimaging
- Alzheimer's Disease Research
- Computational Neuroscience
Background:
- Predicting dementia risk is crucial for early Alzheimer's disease (AD) management.
- Brain structure volumes deviate from normal trajectories in individuals with AD.
- Analyzing deviations from expected age and sex-based volumetric measurements can predict AD progression risk.
Purpose of the Study:
- To predict individual Alzheimer's disease progression risk.
- To analyze deviations from age and sex-based volumetric measurements of brain structures.
- To identify individuals at high risk for AD conversion.
Main Methods:
- Utilized T1w MRI scans from multiple large-scale databases.
- Modeled healthy aging trajectories for 70 brain regions using Bayesian multilevel models and cubic b-splines.
- Employed a linear Survival Support Vector Machine with permutation importance to predict time-to-event for AD conversion.
Main Results:
- Achieved a concordance index of 0.82(0.04) in predicting AD conversion risk.
- Identified baseline diagnosis (Cognitively Normal or Mild Cognitive Impairment) as a key predictor.
- Highlighted the importance of baseline volumes in the Amygdala, Inferior lateral ventricles, Superior temporal gyrus, and Superior frontal gyrus.
Conclusions:
- Developed a library of healthy aging trajectories for 70 anatomical structures.
- Demonstrated the effectiveness of the method in identifying subjects at high risk of progressing to Alzheimer's Dementia.
- The approach offers a novel way to assess AD progression risk using neuroimaging data.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Imaging Studies III: Computed Tomography
Imaging Studies IV: Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...